Onset
Not established; any same-day reports are anecdotal.
Protocol / Research Dosing Guide
Glow Blend Dosage Guide: What Is In It, Reconstitution and Safety
An evidence-organized guide to the three-component Glow research blend, separating vendor marketing from what has actually been studied — which is the individual ingredients, never the mixture.
Last reviewed September 16, 202618 minute readResearch information only
Level 1 — Blend not directly studiedNo combination evidenceNot FDA approved
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Quick Start
Glow is a commercial name for a pre-mixed research vial sold as a GHK-Cu, BPC-157 and TB-500 combination — essentially the Klow blend without KPV. No study of this fixed combination in humans, animals, or cell systems was identified. Evidence for each component belongs to that component alone and does not transfer to the mixture.
Why researchers care
Skin, collagen and combined repair-signaling research claims
Class
Vendor-defined GHK-Cu + BPC-157 + TB-500 blend
Route reported
Vendor listings describe subcutaneous injection of a reconstituted blend
Cycle length
Not established for the combination
Regulatory status
Not FDA approved; research-use product
Loading supplier information
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Dosing Protocol and Schedule
The vendor listing reviewed (a 70 mg vial) does not publish a per-component breakdown, so the amount of each ingredient in the vial is not verified. No studied schedule exists for the combination; any schedule shown by a seller is a marketing convention, not a studied regimen.
| Phase or study | Amount | Frequency / evidence |
|---|---|---|
| Combination schedule | Not established | No controlled study of this blend exists |
| Per-component amounts in the vial | Not published on the reviewed listing | Fixed ratios cannot be adjusted independently |
| Rest or repeat interval | Not established | No combination study defines one |
No study establishes an appropriate human amount, frequency, cycle, rest period, or taper for this blend. Component-level findings cannot be summed into a blend protocol.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Supplies Needed
Neutral research-material planning only. This does not establish an appropriate amount or route.
Research planning item
Exact labeled research vial
Research planning item
Measured diluent volume
Research planning item
U-100 measurement reference
Research planning item
Alcohol swabs
Research planning item
Appropriate sharps container
Research planning item
Written concentration label
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Reconstitution Calculator
Vial-format concentration math
Concentration
23.333 mg/mL
Draw volume
0.15 mL
U-100 units
15
Mathematical draws
20
Arithmetic only. The entered amount is not a recommendation and does not establish suitability.
Best Time to Take GHK-Cu + BPC-157 + TB-500 Blend (Glow): Morning or Night?
Morning or evening?
Not established. No blend study examines timing.
Daily or intermittent?
Not established for the combination.
With food?
Not applicable to an injected vial format and not established for any other format.
Missed amount?
No validated replacement or doubling procedure exists.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Route Comparison
| Route | What is reported | Evidence limit |
|---|---|---|
| Subcutaneous | Vendor listings describe a reconstituted injectable blend | No blend-level human study |
| Topical or cosmetic | GHK-Cu appears in cosmetic products on its own | Does not establish blend use by any route |
| Oral | Not established | No blend exposure data |
| Route conversion | None available | Routes are not interchangeable |
Routes and amounts are not interchangeable unless a verified study explicitly establishes a conversion.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Half-Life and Dosing Frequency
| Measure | Finding | Evidence limit |
|---|---|---|
| Blend half-life | Not established | No combination pharmacokinetic study |
| GHK-Cu human half-life | Not established | No formal human PK study identified |
| BPC-157 human half-life | Not established | Animal PK cannot define human clearance |
| TB-500 fragment half-life | Not established | No formal PK study identified |
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Dosage Chart
| Route | Amount | Frequency | Source | Human validation |
|---|---|---|---|---|
| Subcutaneous blend | Not established | — | No studied regimen | No |
| Per-component amount | Not published on listing | — | Vendor listing | No |
Published study values describe those studies. Community-reported values are not validated dosing recommendations.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Reconstitution Guide
Concentration: 23.333 mg/mL
| Entered amount | Volume | U-100 units |
|---|---|---|
| 3.5 mg | 0.15 mL | 15 units |
| 7 mg | 0.3 mL | 30 units |
| 10.5 mg | 0.45 mL | 45 units |
- 1.Confirm the exact vial label and total quantity.
- 2.Record the measured diluent volume.
- 3.Clean the vial stopper.
- 4.Add liquid slowly along the vial wall.
- 5.Swirl gently; do not shake.
- 6.Inspect for cloudiness, discoloration, or particles.
- 7.Label the calculated concentration and preparation date.
- 8.Use the result only for arithmetic, not as a recommendation.
Reconstitution does not establish identity, purity, sterility, stability, or an appropriate amount.
How GHK-Cu + BPC-157 + TB-500 Blend (Glow) Works
GHK-Cu component
A copper tripeptide studied mostly in cell and cosmetic-formulation research; findings do not test this blend.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Human Trials and FDA Status
Current status · verified September 16, 2026
Not FDA approved; research-use product
- No controlled human trial of the GHK-Cu + BPC-157 + TB-500 combination was identified.
- No controlled animal study of the fixed blend was identified.
- Component studies cannot establish combination efficacy or safety.
- The blend has no FDA-approved indication.
Who Should Avoid GHK-Cu + BPC-157 + TB-500 Blend (Glow)?
This is an evidence-gap and precaution list, not an approved prescribing label.
Pregnancy or breastfeeding
No safety data
Children or adolescents
No safety data
Active or recent cancer
Angiogenesis-related concerns are unresolved
Known ingredient sensitivity
Identity and excipient uncertainty
Concurrent medicines
No interaction studies
Long-term or repeated use
No safety data
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Side Effects, Risks and Safety
Injection-site irritationCommunity reported
Important limitation: No controlled incidence data.
Nausea, lightheadedness, or fatigueCommunity reported
Important limitation: Causality is not established.
Tumor-related riskTheoretical
Important limitation: No blend carcinogenicity study.
Immune reactionUnknown
Important limitation: No characterized blend immunogenicity data.
Drug interactionsUnknown
Important limitation: No interaction studies.
Long-term effectsUnknown
Important limitation: No follow-up evidence.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Timeline and Monitoring
Peak effect
Not established.
Cycle length
Not established for the combination.
Monitoring
No validated biomarker panel, stopping rule, or follow-up schedule exists.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Benefits and Results: What the Evidence Shows
| Claim | Evidence level | What research shows | Important limitation |
|---|---|---|---|
| Skin quality or collagen | Not established for blend | Component cosmetic and cell research | No combination study |
| Tissue repair | Not established for blend | Component animal findings | No controlled human blend data |
| Inflammation | Not established for blend | Mechanistic inference | Fixed-ratio effects unknown |
| Hair or scalp effects | Not established for blend | Extrapolated from copper-peptide research | No direct evidence |
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Storage and Handling
Unreconstituted vial
No blend-specific stability study was identified; follow the exact product label.
Prepared vial
Community refrigeration guidance is not validated stability evidence.
Mixed formulation
Co-formulation effects and degradation kinetics are not established.
Appearance
Cloudiness, discoloration, or particles do not establish sterility or usability.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Troubleshooting
The solution looks abnormal
Stop and seek qualified product guidance; appearance cannot confirm sterility.
The units do not match another chart
Recheck total blend mg, liquid volume, entered amount, and U-100 conversion.
Per-component quantities are unclear
The reviewed listing does not publish them; do not assume an equal split.
A component claim is presented as blend evidence
Return to the exact study product; component evidence does not transfer.
A scheduled amount is missed
No validated missed-amount procedure exists.
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Comparisons
| Compound | Class or mechanism | Evidence | FDA status |
|---|---|---|---|
| Glow | Three-component vendor blend | No direct studies | Not approved |
| Klow | Four-component vendor blend (adds KPV) | No direct studies | Not approved |
| GHK-Cu | Copper tripeptide | Cell and cosmetic-formulation research | Not approved |
| BPC-157 | 15-amino-acid peptide | Mostly animal; very limited human reports | Not approved |
| TB-500 | Thymosin-related fragment | Limited and indirect evidence | Not approved |
GHK-Cu + BPC-157 + TB-500 Blend (Glow) Frequently Asked Questions
What is Glow?
A commercial name for a pre-mixed GHK-Cu, BPC-157 and TB-500 research vial — the Klow blend without KPV.
Has the blend been studied in humans?
No controlled human blend study was identified.
Has it been studied in animals?
No controlled study of the fixed blend was identified.
How much of each ingredient is in the vial?
The reviewed 70 mg listing does not publish a per-component breakdown, so the split is not verified.
Is it FDA approved?
No.
What is its half-life?
Not established for the blend.
Can component evidence be assigned to Glow?
No. Evidence does not transfer to a mixture.
Is a cycle or rest period established?
No.
What does the calculator do?
It converts entered total-vial and liquid values into concentration and volume math only.
Sources and Research
Vendor listing
1. Glow 70mg product listing
Vendor listing confirming vial size and price; not evidence of effect.
Open direct sourceComponent animal research
2. Pharmacokinetics of BPC157 in rats and dogs
Component-only animal PK across several routes; does not test the blend.
Open direct sourceComponent review
3. GHK-Cu skin biology review
Component-only review of copper-peptide skin research; does not test the blend.
Open direct sourceMissing information flagged for review
- Blend identity and pharmacology study: Not established
- Controlled human or animal blend evidence: Not established
- Verified per-component vial breakdown: Not established
- Human dose and route: Not established
- Blend half-life and pharmacokinetics: Not established
- Validated cycle and rest period: Not established
- Blend-specific stability: Not established
- Long-term safety: Not established